|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00455 TIANDA PHARMA
Nominal 
0.160 -0.025 (-13.514%) | 2024/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2023/06 HKD(K$) | 2022/09 HKD(K$) | 2021/09 HKD(K$) | 2020/09 HKD(K$) | |
| Turnover | 156,073 | -48.573% | 303,484 | 249,856 | 236,520 | 187,364 |
| Cost of Sales | (80,228) | -45.933% | (148,387) | (127,668) | (125,604) | (63,052) |
| Gross Profit | 75,845 | -51.098% | 155,097 | 122,188 | 110,915 | 124,312 |
| 2024/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2023/06 HKD(K$) | 2022/09 HKD(K$) | 2021/09 HKD(K$) | 2020/09 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (25,200) | 352.505% | (5,569) | (20,197) | (18,197) | (17,742) | |
| Taxation | (2,025) | -- | 658 | 1,073 | 199 | 2,151 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (11) | -- | 784 | 2,775 | 50 | 40 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (27,236) | 559.947% | (4,127) | (16,349) | (17,947) | (15,551) | |
| 2024/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2023/06 HKD(K$) | 2022/09 HKD(K$) | 2021/09 HKD(K$) | 2020/09 HKD(K$) | |
| Net Finance Costs / (Income) | 2,433 | -1.737% | 2,476 | 3,282 | 383 | 149 |
| Depreciation & Amortisation | 18,570 | 5.284% | 17,638 | 19,223 | 10,904 | 9,976 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/09 | 2021/09 | 2020/09 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/09 | 2021/09 | 2020/09 | |
| EPS (cts) | -1.270 | 568.421% | -0.190 | -0.760 | -0.830 | -0.720 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 0.253 | -- | 0.280 | 0.300 | 0.345 | 0.343 |
| Remarks: | Real time quote last updated: 27/12/2024 17:38 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD -27,236,000 |
| %Change | 559.947% |
| EPS / (LPS) | HKD -0.013 |
| NBV Per Share ($) | HKD 0.253 |